Home | Subscribe for Free!
Discussing the Latest in Implant Dentistry

Osteonecrosis Risk from Bisphosphonates?

David, a dentist, comments:
I am wondering if anyone has any comments on a recent study out of U of P Dental School that concluded that, “On the basis of 2 controlled clinical studies, oral bisphosphonate usage was not associated with occurrence of  osteonecrosis of the jaws (ONJ).” Do you think future studies will support this non-association or is the link between bisphosphonates and ONJ still a major concern despite this recent data?

Continue reading "Osteonecrosis Risk from Bisphosphonates?"

October 3, 2006 in Dental Implant Complications, Oral Bisphosphonates | Permalink | Comments (6)

ADA Comments on Oral Bisphosphonates

In this month´s JADA, the ADA finally chimed in with their guidelines for patients who are on oral bisphosphonates.

Continue reading "ADA Comments on Oral Bisphosphonates"

August 7, 2006 in Dental Implant News, Oral Bisphosphonates | Permalink | Comments (0)

Oral Bisphosphonates

Dr. Jeffries asks us:

I'm trying to get a barometer on the prevailing opinion for dental implant placement on patients taking oral bisphosphonates (Fosamax, Actonel, etc.)

Continue reading "Oral Bisphosphonates"

May 29, 2006 in Dental Implant Contraindications, Oral Bisphosphonates | Permalink | Comments (4)

Oral Bisphosphonates, Osteonecrosis, and Dental Implants

Dr. Gold submits:

About 80 million people in the US alone take bisphosphonates for cancer, osteoperosis, etc. It is clear that patients who have received IV bisphosphonates are at high risk for osteonecrosis in the mandible and maxilla.

Continue reading "Oral Bisphosphonates, Osteonecrosis, and Dental Implants"

February 19, 2006 in Dental Implant Contraindications, Oral Bisphosphonates | Permalink | Comments (56)

Medications and Dental Implant Placement

Medications have a profound effect on a patient's oral condition.

Continue reading "Medications and Dental Implant Placement"

October 17, 2005 in Oral Bisphosphonates | Permalink | Comments (3)

Featured Sponsor


home |